Literature DB >> 16823458

Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1.

M Aspiotis1, E Tsanou, S Gorezis, E Ioachim, A Skyrlas, M Stefaniotou, V Malamou-Mitsi.   

Abstract

PURPOSE: This retrospective study aims to elucidate the role of angiogenesis in the pathogenesis of pterygium. We evaluated microvessel density (MVD), and expression of vascular endothelial growth factor (VEGF) and thrombospondin-1 (TSP-1).
METHODS: Fifty-two surgically excised pterygia and seven normal conjunctivae were immunohistochemically studied applying the streptavidin-biotin method in paraffin-embedded tissue sections. Monoclonal antibodies were targeted against CD31, VEGF, and TSP-1 proteins.
RESULTS: Pterygium presented with statistically significant higher average count of microvessels compared to normal conjunctivae (17.97+/-8.5 vs5.72+/-5 per high power field, P=0.001). In 24/52 (46.2%) cases of pterygium, high expression levels for VEGF were demonstrated, whereas the mean percentage of VEGF-positive epithelial cells was 58.03%. Furthermore, normal conjunctival presented statistically significant higher expression levels for VEGF in epithelial cells (83.14+/-36.08 vs58.03+/-31.23%, P=0.007). On the contrary, the presence of VEGF immunoreactivity in vascular endothelial and stromal cells was significantly higher in pterygium tissues (P<0.0001). Stromal staining for TSP-1 was detected in only 29/52 (55.8%) of the cases and no correlation with normal conjunctivae was found. Finally, statistically significant positive correlation between MVD values and stromal VEGF expression was found (P=0.049).
CONCLUSION: The angiogenesis-related factors that were studied proved to be highly expressed in pterygium tissue. On the contrary, TSP expression level was low, allowing inducers of angiogenesis to act uninhibited. This phenomenon could provide the pathogenic basis of pterygium formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823458     DOI: 10.1038/sj.eye.6702495

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  30 in total

1.  Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.

Authors:  Angel Nava-Castañeda; Isabel Ulloa-Orozco; Lilia Garnica-Hayashi; Joaquín Hernandez-Orgaz; Maria Carmen Jimenez-Martinez; Yonathan Garfias
Journal:  J Ocul Pharmacol Ther       Date:  2014-11-04       Impact factor: 2.671

2.  EphB4 expression in pterygium is associated with microvessel density.

Authors:  Chunyan Xue; Yueqin Chen; Zhenping Huang; Yirui Ge; Haiyan Wang; Jiandong Wang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?

Authors:  Aylin Karalezli; Cem Kucukerdonmez; Yonca A Akova; Bengu Ekinci Koktekir
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

4.  Bibliometric analysis and mapping knowledge domain of pterygium: 2000-2019.

Authors:  Yu-Chi Wang; Fang-Kun Zhao; Qian Liu; Zi-Yan Yu; Jing Wang; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

5.  Correlation of vascular endothelial growth factor and CD105-microvascular density in primary pterygium.

Authors:  Jie Zhang; Mingchang Zhang; Xiaoqing Li; Tian Zheng; Ge Mu; Wei Liu; Huatao Xie; Xin Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

6.  Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells.

Authors:  Laura Soriano-Romaní; Laura Contreras-Ruiz; Laura García-Posadas; Antonio López-García; Sharmila Masli; Yolanda Diebold
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-08       Impact factor: 2.671

7.  Correlation between NGF/TrkA and microvascular density in human pterygium.

Authors:  Domenico Ribatti; Beatrice Nico; Maria Teresa Perra; Cristina Maxia; Franca Piras; Daniela Murtas; Enrico Crivellato; Paola Sirigu
Journal:  Int J Exp Pathol       Date:  2009-09-15       Impact factor: 1.925

8.  Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study.

Authors:  Tarek A Mohamed; Wael Soliman; Ahmed M Fathalla; Abeer El Refaie
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

9.  Ocular microvascular alteration in Sjögren syndrome.

Authors:  Qi-Chen Yang; Fan Yao; Qiu-Yu Li; Min-Jie Chen; Li-Juan Zhang; Hui-Ye Shu; Rong-Bin Liang; Yi-Cong Pan; Qian-Min Ge; Yi Shao
Journal:  Quant Imaging Med Surg       Date:  2022-02

10.  Distinct gene subsets in pterygia formation and recurrence: dissecting complex biological phenomenon using genome wide expression data.

Authors:  Louis Tong; Jaime Chew; Henry Yang; Leonard P K Ang; Donald T H Tan; Roger W Beuerman
Journal:  BMC Med Genomics       Date:  2009-03-10       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.